Al Altomari
2020
In 2020, Al Altomari earned a total compensation of $2.4M as Chairman & Chief Executive Officer at Agile Therapeutics, a 84% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $310,145 |
|---|---|
| Option Awards | $1,427,166 |
| Salary | $554,783 |
| Stock Awards | $75,001 |
| Other | $29,124 |
| Total | $2,396,219 |
Altomari received $1.4M in option awards, accounting for 60% of the total pay in 2020.
Altomari also received $310.1K in non-equity incentive plan, $554.8K in salary, $75K in stock awards and $29.1K in other compensation.
Rankings
In 2020, Al Altomari's compensation ranked 4,740th out of 13,090 executives tracked by ExecPay. In other words, Altomari earned more than 63.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,740 out of 13,090 | 64th |
Division Manufacturing | 1,928 out of 5,624 | 66th |
Major group Chemicals And Allied Products | 757 out of 2,257 | 67th |
Industry group Drugs | 650 out of 1,957 | 67th |
Industry Pharmaceutical Preparations | 491 out of 1,462 | 66th |
Source: SEC filing on April 29, 2022.
Altomari's colleagues
We found one more compensation record of an executive who worked with Al Altomari at Agile Therapeutics in 2020.
2020
Geoffrey Gilmore
Agile Therapeutics